Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Multani Pharmaceuticals Limited, is an unlisted public company incorporated on 05 March, 1986. It is classified as a public limited company and is located in South Delhi, Delhi. It's authorized share capital is INR 6.00 cr and the total paid-up capital is INR 2.16 cr.
Multani Pharmaceuticals Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 4.26% over the previous year. At the same time, it's book networth has increased by 25.25%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
9.45%
-4.26%
-8.93%
25.25%
-66.0%
5.35%
2.5
-2.42
-2.17
-7.78
-8.63
-0.02
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(13)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Punjab National Bank
No. of Loans: 2
Total Amount : 24.2 cr
Small Industries Development Bank of India
No. of Loans: 1
Total Amount : 1.5 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Pradeep Multani
Shareholder
|
00109071 | 39 years |
| Director | Rajesh Sabharwal | 00636236 | 6 years |
| Director | Yogesh Sahni | 00811667 | 6 years |
| Director | Sanjay Kumar
Shareholder
|
09271907 | 2 years |
| Director | Vinay Rungta | 09846999 | 2 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| MULTANI PROPERTIES AND INVESTMENT CO PVT LTD |
Active
|
17.6 L | 1 | Delhi |
| KUKA HEALTH FOODS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Delhi |
| KUKA FINANCE AND LEASING PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Delhi |
| KUKA HERBALS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Delhi |
| NATURE TO SKIN CARE PRIVATE LIMITED |
Active
|
1.0 L | 2 | Delhi |
| MULTANI WELLNESS PRIVATE LIMITED |
Active
|
5.0 L | 1 | Delhi |
| YELLOW HUT PROPERTIES LLP |
Active
|
1.0 L | 1 | Delhi |
| SIM MAN DEVI AGRO LLP |
Active
|
5.0 L | 1 | Delhi |
| ADM AGROVET LLP |
Active
|
1.3 Cr | 1 | Delhi |
| JMD ASU AGRO LLP |
Active
|
5.0 L | 1 | Delhi |
| MANYA DEVI AGROVET LLP |
Active
|
5.0 L | 1 | Delhi |
| MEHER SIM AGROTECH LLP |
Active
|
5.0 L | 1 | Delhi |
| KUKA ORGANIC AGRO LLP |
Active
|
1.7 Cr | 1 | Delhi |
| CINZIA AGROTECH LLP |
Active
|
5.0 L | 1 | Delhi |
| NJM AGROTECH LLP |
Active
|
5.0 L | 1 | Delhi |
| AJM AGROVET LLP |
Active
|
5.0 L | 1 | Delhi |
| GURU ELECTRO SYSTEMS PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Delhi |
| Y & Y APPLIANCES PRIVATE LIMITED |
Active
|
12.0 L | 1 | Delhi |
| GURUTECH INDUSTRIES LLP |
Active
|
1.5 Cr | 1 | Delhi |
| STAMPING & MORE LLP |
Active
|
60.0 L | 1 | Delhi |
| GURU TECHNOLOGIES LLP |
Active
|
10.0 L | 1 | Delhi |
| WONDER ELECTRICALS LIMITED |
Active
|
33.3 Cr | 1 | Delhi |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| MULTANI INFRA & AGRO PRIVATE LIMITED | Delhi | 2020 | ₹ 5.0 L |
| KUKA ORGANIC AGRO LLP | India | - | - |
| NATURE TO SKIN CARE PRIVATE LIMITED | Delhi | 2021 | ₹ 1.0 L |
| JMD ASU AGRO LLP | India | - | - |
| ADM Agrovet LLP | India | - | - |
| Manya Devi Agrovet LLP | India | - | - |
| Meher SIM Agrotech LLP | India | - | - |
| SIM Man Devi Agro LLP | India | - | - |
The incorporation date of MULTANI PHARMACEUTICALS LIMITED is 05 March, 1986
The authorized share capital of MULTANI PHARMACEUTICALS LIMITED is INR ₹ 6.0 Cr.
The paid-up capital of MULTANI PHARMACEUTICALS LIMITED is INR ₹ 2.2 Cr.
The registered address of MULTANI PHARMACEUTICALS LIMITED is T-10 OKHLA INDUSTRIAL AREA PHASE - II NEW DELHI South Delhi Delhi - 110020
The CIN number of MULTANI PHARMACEUTICALS LIMITED is U24230DL1986PLC023539.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
